Paper
The Oriented Development of Antituberculotics (Part II): Halogenated 3‐(4‐Alkylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐diones
Published May 1, 2007 · K. Waisser, Josef Matyk, Hana Divišová
Archiv der Pharmazie
Q2 SJR score
15
Citations
1
Influential Citations
Abstract
Based on our previous studies, 21 new halogenated 3‐(4‐alkylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐diones were synthesized by the reaction of salicylanilides and methyl‐chloroformate. All compounds were screened in vitro against three different strains of mycobacterium, and Free‐Wilson method was used to establish structure‐activity relationships. 6‐Bromo‐3‐(4‐butylphenyl)‐1,3‐benzoxazine‐2,4‐(3H)‐dione 3b proved to be the most active compound of the series.
Study Snapshot
Halogenated 3(4-alkylphenyl)1,3benzoxazine2,4(3H)diones show potential as antituberculotics, with 6Bromo-3(4-butylphenyl)1,3
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Full text analysis coming soon...
References
···
···
···
···
Citations
···
···
···
···